Mucosal and systemic immunization with targeted fusion anti-caries DNA plasmid in young rats

Vaccine

Volumn 27, Issue 22, 2009, Pages 2940-2947

  Liu, G X ^a   Xu, Q A ^a   Jin, J ^a   Li, Y H ^a   Jia, R ^a   Guo, J H ^a   Fan, M W ^a  

^a Wuhan University   (China)

Author keywords

Dental caries; DNA vaccine; Early life immunity

Indexed keywords

ANTICARIES AGENT; BUPIVACAINE; CYTOKINE; DNA VACCINE; DNA VACCINE BUPIVACAINE COMPLEX; GAMMA INTERFERON; GLUCOSYLTRANSFERASE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MEMBRANE ANTIGEN; PLASMID DNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENTAL CARIES; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RAT; SALIVA; STREPTOCOCCUS MUTANS;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; DENTAL CARIES; FEMALE; IMMUNITY, MUCOSAL; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; PLASMIDS; PREGNANCY; RATS; RECOMBINANT FUSION PROTEINS; SALIVA; SERUM; STREPTOCOCCAL VACCINES; STREPTOCOCCUS MUTANS; VACCINES, DNA; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 65049090378     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.03.009     Document Type: Article

References (51)

1. Qi X.Q. The third national epidemiological survey of oral health (2008), People's Health Publishing Bureau, Beijing
2. Hamada S., and Slade H.D. Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev 44 2 (1980) 331-384
3. Loesche W.J. Role of Streptococcus mutans in human dental decay. Microbiol Rev 50 4 (1986) 353-380
4. Yamashita Y., Bowen W.H., Burne R.A., and Kuramitsu H.K. Role of the Streptococcus mutans gtf genes in caries induction in the specific-pathogen free rat model. Infect Immun 61 90 (1993) 3811-3817
5. Koga T., Asakawa H., Okahashi N., and Hamada S. Sucrose-dependent cell adherence and cariogenicity of serotype c Streptococcus mutans. J Gen Microbiol 132 10 (1986) 2873-2883
6. Koga T., Olahashi N., Takahashi I., Kanamoto T., Asakawa H., and Iwaki M. Surface hydrophobicity, adherence, and aggregation of cell surface protein antigen of Streptococcus mutans serotype c. Infect Immun 58 2 (1990) 289-296
7. Bowen W.H., Schilling K., Giertsen E., Pearson S., Lee S.F., Bleiweis A., et al. Role of a cell surface-associated protein in adherence and dental caries. Infect Immun 59 12 (1991) 4606-4609
8. Kuramitsu H.K. Virulence factors of mutans streptococci: role of molecular genetics. Crit Rev Oral Biol Med 4 2 (1993) 159-176
9. Monchois V., Willemot R.M., and Monsan P. Glucansucrases: mechanism of action and structure-function relationships. FEMS Microbiol Rev 23 2 (1999) 131-151
10. Russell M.W., and Mansson-Rahemtulla B. Interaction between surface protein antigens of Streptococcus mutans and human salivary components. Oral Microbiol Immunol 4 2 (1989) 106-111
11. Katz J., Harmon C.C., Buckner G.P., Richardson G.J., Russell M.W., Michalek S.M., et al. Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin. Infect Immun 61 5 (1993) 1964-1971
12. Smith D.J., King W.F., Rivero J., and Taubman M.A. Immunological and protective effects of diepitopic subunit dental caries vaccines. Infect Immun 73 5 (2005) 2797-2804
13. Taubman M.A., Holmberg C.J., and Smith D.J. Diepitopic construct of functionally and epiopocally complementary peptides enhances immunogenicity, reactivity with glucosyltransferase, and protection from dental caries. Infect Immun 69 7 (2001) 4210-4216
14. Zhang P., Jespersgaard C., Lamberty-Mallory L., Katz J., Huang Y., Hajishengalllis G., et al. Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection. Infect Immun 70 12 (2002) 6779-6787
15. Jespersgaad C., Hajishengalllis G., Huang Y., Russell M.W., Smith D.J., and Michaled S.M. Protective immunity against Streptococcus mutans infection in mice after intranasal immunization with the glucan-binding region of S. mutans glucosyltransferase. Infect Immun 67 12 (1999) 6543-6549
16. Taubman M.A., Smith D.J., Holmberg C.J., and Eastcott J.W. Coimmunization with complementary glucosyltransferase peptides results in enhanced immunogenicity and protection against dental caries. Infect Immun 68 5 (2000) 2698-2703
17. Fan M.W., Bian Z., Peng Z.X., Zhong Y., Chen Z., Peng B., et al. A DNA vaccine encoding a cell-surface protein antigen of Streptococcus mutans protects gnotobiotic rats from caries. J Dent Res 81 11 (2002) 784-787
18. Guo J.H., Jia R., Fan M.W., Bian Z., Chen Z., and Peng B. Construction and immunogenic characterization of a fusion anti-caries DNA vaccine against PAc and glucosyltransferase I of Streptococcus mutans. J Dent Res 83 3 (2004) 266-270
19. Jia R., Guo J.H., Fan M.W., Bian Z., Chen Z., Fan B., et al. Immunogenicity of CTLA-4 fusion anti-caries DNA vaccine in rabbits and monkeys. Vaccine 24 24 (2006) 5192-5200
20. Xu Q.A., Yu F., Fan M., Bian Z., Guo J.H., Jia R., et al. Immunogenicity and protective efficacy of a targeted fusion DNA construct against dental caries. Caries Res 39 5 (2005) 422-431
21. Xu Q.A., Yu F., Fan M.W., Bian Z., Chen Z., Fan B., et al. Immunogenicity and persistence of a targeted anti-caries DNA vaccine. J Dent Res 85 10 (2006) 915-918
22. Caufield P.W., Cutter G.R., and Dasanayake A.P. Initial acquisition of mutans streptococci by infants: evidence for a discrete window of infectivity. J Dent Res 72 1 (1993) 37-45
23. Li Y., and Caufield P.W. The fidelity of initial acquisition of mutans streptococci by infants from their mothers. J Dent Res 74 2 (1995) 681-685
24. Smith D.J., King W.F., Akita H., and Taubman M.A. Association of salivary immunoglobulin A antibody and initial mutans streptococcal infection. Oral Microbiol Immunol 13 5 (1998) 278-285
25. Smith D.J., and Taubman M.A. Ontogeny of immunity to oral microbiota in humans. Crit Rev Oral Biol Med 3 1-2 (1992) 109-133
26. Smith D.J., and Taubman M.A. Emergence of immune competence in saliva. Crit Rev Oral Biol Med 4 3-4 (1993) 335-341
27. Taubman M.A., and Nash D.A. The scientific and public-health imperative for a vaccine against dental caries. Nat Rev Immunol 6 7 (2006) 555-563
28. Tappuni A.R., and Challacombe S.J. A comparison of salivary immunoglubulin A (IgA) and IgA subclass concentration in predentate and dentate children and adults. Oral Microbiol Immunol 9 3 (1994) 142-145
29. Oho T., Shimazaki Y., Mitoma M., Yoshimura M., Yamashita Y., Okano K., et al. Bovine milk antibodies against cell surface protein antigen PAc-glucosyltransferase fusion protein suppress cell adhesion and alter glucan synthesis of Streptococcus mutans. J Nutr 129 10 (1999) 1836-1841
30. Jespersgaard C., Hajishengallis G., Greenway T.E., Smith D.J., Russell M.W., and Michalek S.M. Functional and immunogenic characterization of two cloned regions of Streptococcus mutans glucosyltransferase-I. Infect Immun 67 2 (1999) 810-816
31. Pachuk C.J., Ciccarelli R.B., Samuel M., Bayer M.E., Troutman R.D., Zurawski D.V., et al. Characterization of a new class of DNA delivery complexes formed by the local anesthetic bupivacaine. Biochim Biophys Acta 1468 1-2 (2000) 20-30
32. Keyes P.H. Dental caries in the molar teeth of rats. II. A method for diagnosing and scoring several types of lesions simultaneously. J Dent Res 37 6 (1958) 1088-1099
33. Ichino M., Mor G., Conover J., Weiss W.R., Takeno M., Ishii K.J., et al. Factors associated with the development of neonatal tolerance after the administration of a plasmid DNA vaccine. J Immun 162 7 (1999) 3814-3818
34. Bot A., Shearer M., Bot S., Avriette M., Garcia-Sastre A., White G., et al. Induction of immunological memory in baboons primed with DNA vaccine as neonates. Vaccine 19 15-16 (2001) 1960-1967
35. Neurath M.F., Finotto S., and Glimcher L.H. The role of Th1/Th2 polarization in mucosal immunity. Nat Med 8 6 (2002) 567-573
36. Han T.K., and Dao M.L. Enhancement of salivary IgA response to a DNA vaccine against Streptococcus mutans wall-associated protein A in mice by plasmid-based adjuvants. J Med Microbiol 56 Pt 5 (2007) 675-680
37. Huang X., Xu J., Qiu C., Ren L., Liu L., Wan Y., et al. Mucosal priming with PEI/DNA complex and systemic boosting with recombinant TianTan vaccinia stimulate vigorous mucosal and systemic immune responses. Vaccine 25 14 (2007) 2620-2629
38. Sasaki S., Sumino K., Hamajima K., Fukushima J., Ishii N., Kawamoto S., et al. Induction of systemic and mucosal immune responses to human immunodeficiency virus type1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes. J Virol 72 6 (1998) 4931-4939
39. Bot A., and Bona C. Genetic immunization of neonates. Microbes Infect 4 4 (2002) 511-520
40. Vaughan K., Rhodes G.H., and Gershwin L.J. DNA immunization against respiratory syncytial virus (RSV) in infant rhesus monkeys. Vaccine 23 22 (2005) 2928-2942
41. Cuburu N., Kweon M.N., Song J.H., Hervouet C., Luci C., Sun J.B., et al. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine 25 51 (2007) 8598-8610
42. Song J.H., Nguyen H.H., Cuburu N., Horimoto T., Ko S.Y., Park S.H., et al. Sublingual vaccination with influenza virus protects miceagainst lethal viral infection. Proc Natl Acad Sci USA 105 5 (2008) 1644-1649
43. Huang C.F., Wu T.C., Chu Y.H., Hwang K.S., Wang C.C., and Peng H.J. Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice. Scand J Immunol 68 5 (2008) 502-510
44. Hinkula J., Hagbom M., Wahren B., and Schroder U. Safety and immunogenicity after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice. Vaccine 26 40 (2008) 5101-5106
45. Bråve A., Hallengärd D., Schröder U., Blomberg P., Wahren B., and Hinkula J. Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses. Vaccine 26 40 (2008) 5075-5078
46. Kweon M.N., Fujihashi K., Vancott J.L., Higuchi K., Yamamoto M., McGhee J.R., et al. Lack of orally induced systemic unresponsiveness in IFN-γ knockout mice. J Immunol 160 4 (1998) 1687-1693
47. Xu-Amano J., Kiyono H., Jackson R.J., Staats H.F., Fujihashi K., Burrows P.D., et al. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induced Th2 cells in mucosa associated tissues. J Exp Med 178 4 (1993) 1309-1320
48. Challacombe S.J. Serum and salivary antibodies to Streptococcus mutans in relation to the development and treatment of human dental caries. Arch Oral Biol 25 7 (1980) 495-502
49. Matsushita K., Nisizawa T., Nagaoka S., Kawagoe M., and Koga T. Identification of antigenic epitopes in a surface protein antigen of Streptococcus mutans in humans. Infect Immun 62 9 (1994) 4034-4042
50. Chia J.S., Chang W.C., Yang C.S., and Chen J.Y. Salivary and serum antibody response to Streptococcus mutans antigens in humans. Oral Microbiol Immunol 15 2 (2000) 131-138
51. Fukuizumi T., Inoue H., Tsujisawa T., and Uchiyama C. Tonsillar application of formalin-killed cells of Streptococcus sobrinus reduces experimental dental caries in rabbits. Infect Immun 67 1 (1999) 426-428